PH: pulmonary hypertension; ECG: electrocardiogram; ESKD-PH: end-stage kidney disease-related pulmonary hypertension; AV: arteriovenous.
* In the absence of a cardiac rhythm device with transvenous leads.
ΒΆ Echocardiographic evaluation includes determining the probability of PH using the tricuspid regurgitant jet velocity (TRV), which can also be used to estimate the pulmonary artery (PA) systolic pressure (ePASP); assess RV size, wall thickness, and function; and assess the potential contribution of left-sided heart disease to PH.